Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot-Marie-Tooth Disease Type 4D in Bulgaria.
Atkinson D, Chamova T, Candayan A, Kastreva K, Asenov O, Litvinenko I, Estrada-Cuzcano A, De Vriendt E, Kukushev G, Tournev I, Jordanova A. Atkinson D, et al. Among authors: litvinenko i. Int J Mol Sci. 2024 Aug 21;25(16):9047. doi: 10.3390/ijms25169047. Int J Mol Sci. 2024. PMID: 39201732 Free PMC article.
Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel.
Molnar MJ, Szabó L, Vladacenco OA, Cobzaru AM, Dor T, Dori A, Papadimas G, Juříková L, Litvinenko I, Tournev I, Dixon C. Molnar MJ, et al. Among authors: litvinenko i. Orphanet J Rare Dis. 2024 Jul 9;19(1):260. doi: 10.1186/s13023-024-03270-2. Orphanet J Rare Dis. 2024. PMID: 38982500 Free PMC article.
[Multi-center open comparative randomized study of efficacy and safety of Akatinol Memantine 20 mg (single-doses) vs Akatinol Memantine 10 mg (double-doses) in patients with vascular dementia].
Gavrilova SI, Kolykhalov IV, Mikhaylova NM, Ponomareva EV, Fedorova YB, Medvedev VE, Frolova VI, Gushanskaya EV, Litvinenko IV, Emelin AY, Lobzin VY, Kashin AV, Tanashyan MM, Kachanova MV, Knyazev AV, Gonik MI. Gavrilova SI, et al. Among authors: litvinenko iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(2):69-77. doi: 10.17116/jnevro202412402169. Zh Nevrol Psikhiatr Im S S Korsakova. 2024. PMID: 38465812 Clinical Trial. Russian.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
[Diagnosis and treatment of early forms of cognitive impairment: possibilities of influencing neuronal energy metabolism. Resolution of the Council of Experts].
Bogolepova AN, Zakharov VV, Illarioshkin SN, Litvinenko IV, Mkhitaryan EA, Pizova NV, Yakupov EZ. Bogolepova AN, et al. Among authors: litvinenko iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(9):131-140. doi: 10.17116/jnevro2023123091131. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37796080 Russian.
[Psychological, psychiatric and neurological aspects of COVID-19].
Chritinin DF, Shamrey VK, Litvinenko IV, Kurasov ES, Tsygan NV, Vainshenker YI. Chritinin DF, et al. Among authors: litvinenko iv. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(4. Vyp. 2):44-51. doi: 10.17116/jnevro202312304244. Zh Nevrol Psikhiatr Im S S Korsakova. 2023. PMID: 37141128 Russian.
99 results